Xentria, Inc.
PrivateLast Round
Growth Equity
Oct 18, 2022
Total Funding Raised
$25M
Company Overview
Xentria, Inc. is a biopharmaceutical company that develops novel biologics and biosimilars for rare diseases, immunologic disorders, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xentria, Inc. Comparables
Compare Xentria, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SarcoMed USA | 81% | |
| Roivant Sciences | 78% | |
| aTyr Pharma | 77% |
Xentria, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 18, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 18, 2022
$25M raised in growth equity round.
Xentria, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xentria, Inc.'s valuation, stock price, and market status.
Is Xentria, Inc. a public or private company?
Xentria, Inc. is a private company.
What is the current stock price of Xentria, Inc.?
Xentria, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Xentria, Inc. worth (valuation)?
Valuation information for Xentria, Inc. is not publicly available.
Can I buy Xentria, Inc. stock?
Xentria, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xentria, Inc.'s last funding round?
Xentria, Inc.'s most recent funding round was Growth Equity on October 18, 2022.
Who are the main investors in Xentria, Inc.?
Investor information for Xentria, Inc. is not publicly disclosed.
Will Xentria, Inc. IPO soon?
No public IPO plans have been announced for Xentria, Inc..
How can I track Xentria, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xentria, Inc.'s secondary market activity and sign up for updates.